Hims & Hers Health Inc (NYSE: HIMS) is 85.73% higher on its value in year-to-date trading and has touched a low of $5.65 and a high of $25.74 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The HIMS stock was last observed hovering at around $16.56 in the last trading session, with the day’s loss setting it -0.03%.
Currently trading at $16.53, the stock is -10.25% and -19.07% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 6.5 million and changing -0.18% at the moment leaves the stock 20.21% off its SMA200. HIMS registered 142.73% gain for a year compared to 6-month gain of 72.01%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -18.73% loss in the last 1 month and extending the period to 3 months gives it a -11.13%, and is 3.44% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 4.80% over the week and 7.86% over the month.
Hims & Hers Health Inc (HIMS) has around 1046 employees, a market worth around $3.59B and $1.07B in sales. Current P/E ratio is 220.99 and Fwd P/E is 30.53. Profit margin for the company is 1.70%. Distance from 52-week low is 192.57% and -35.78% from its 52-week high. The company has generated returns on investments over the last 12 months (4.87%).
with sales reaching $378.45M over the same period.The EPS is expected to grow by 401.30% this year, but quarterly earnings will post 58.30% year-over-year. Quarterly sales are estimated to grow 66.90% in year-over-year returns.
Hims & Hers Health Inc (HIMS) Top Institutional Holders
403.0 institutions hold shares in Hims & Hers Health Inc (HIMS), with institutional investors hold 75.80% of the company’s shares. The shares outstanding are 205.10M, and float is at 163.98M with Short Float at 11.74%. Institutions hold 66.77% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 14.31 million shares valued at $221.38 million. The investor’s holdings represent 6.7633 of the HIMS Shares outstanding. As of 2024-03-31, the second largest holder is BLACKROCK INC. with 10.86 million shares valued at $168.01 million to account for 5.1329 of the shares outstanding. The other top investors are MARSHALL WACE, LLP which holds 5.64 million shares representing 2.6657 and valued at over $87.25 million, while INSTITUTIONAL VENTURE MANAGEMENT XVI, LLC holds 2.4683 of the shares totaling 5.22 million with a market value of $80.79 million.
Hims & Hers Health Inc (HIMS) Insider Activity
Hims & Hers Health Inc disclosed in a document filed with the SEC on Aug 16 ’24 that Becklund Irene (PAO) sold a total of 472 shares of the company’s common stock. The trade occurred on Aug 16 ’24 and was made at $15.66 per share for $7392.0. Following the transaction, the insider now directly holds 2913.0 shares of the HIMS stock.
Still, SEC filings show that on Aug 16 ’24, Becklund Irene (Officer) Proposed Sale 472 shares at an average price of $15.66 for $7392.0. The insider now directly holds shares of Hims & Hers Health Inc (HIMS).
